Central Pharma Contract Holdings Limited
08126719
Some Concerns
- Going concern doubt noted in accounts (-10)
- 2 outstanding charges (-4)
Details
Compliance
Last accounts
31/12/2024
group
Next accounts due
30/09/2026
Confirmation statement
Last: 04/01/2026
Due 18/01/2027
Industry
Officers
director · Since 02/07/2012
DIRECTOR
BRITISH · ENGLAND · Age 65
Also on 5 other boards
director · Since 12/06/2020
SOLICITOR
BRITISH · ENGLAND · Age 57
Also on 52 other boards
Persons with Significant Control
Mr Alwyn Jacobus Nicolaas Smit
South African · Switzerland · Age 65
Central Pharma, Caxton Road, Bedford, MK41 0HT
Notified 06/04/2016
Mr Michael James Blood
British · England · Age 57
Central Pharma, Caxton Road, Bedford, MK41 0HT
Notified 31/08/2018
Former PSCs
Mr Ronald Michael Hene
Ceased 31/08/2018
Charges2 outstanding
CYNERGY BUSINESS FINANCE LIMITED
CLYDESDALE BANK PLC (TRADING AS BOTH CLYDESDALE AND YORKSHIRE BANK) (COMPANY NUMBER SC001111)
THE CO-OPERATIVE BANK PLC
CompanyRankvs 9940+ SIC 64209 peers43
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and the parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. Our responsibilities and the responsibilities of the directors with respect to going co
Key FinancialsYear ending 31/12/2024
Net Worth
£273k
Balance sheet strength
Cash
£37
Cash in the bank
Net Current Assets
-£1.8M
Working capital
Current Assets
—
Current Liabilities
£1.8M
Fixed Assets
£4.5M
Profit After Tax
-£41k
People Costs(2020)
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | — | -£2.6M |
| 2023 | — | -£446k |
| 2022 | 0.00 | +£1.6M |
| 2021 | 0.31 | +£635k |
| 2020 | 0.29 | +£480k |
| 2019 | 0.06 | -£53k |
| 2018 | 0.07 | — |
Derived from filed accounts. Not audited figures.